Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Butte, MT
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Butte, MT
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New York, NY
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Westfield, NY
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Westfield, NY
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Corvallis, OR
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Corvallis, OR
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Medford, OR
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Corpus Christi, TX
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Houston, TX
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Gig Harbor, WA
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Gig Harbor, WA
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Olympia, WA
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Spokane, WA
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Tacoma, WA
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated:  3/7/2018
mi
from
Buenos Aires,
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options
Status: Enrolling
Updated: 3/7/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Fresno, CA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Pomona, CA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Pomona, CA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Atlanta, GA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Peoria, IL
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Albany, IN
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Metairie, LA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Ann Arbor, MI
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Nashua, NH
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Cherry Hill, NJ
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Flemington, NJ
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Flemington, NJ
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Austin, TX
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Dallas, TX
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Georgetown, TX
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Georgetown, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Braunfels, TX
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Midvale, UT
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Midvale, UT
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Ogden, UT
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Olympia, WA
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated:  3/7/2018
mi
from
Curitiba,
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine
Status: Enrolling
Updated: 3/7/2018
mi
from
Curitiba,
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Sacramento, CA
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Walnut Creek, CA
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Aurora, CO
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Denver, CO
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Newark, DE
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Largo, FL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Largo, FL
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Atlanta, GA
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Chicago, IL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials